Laboratory Supplies Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Equipment, Disposables), By Region & Competition, 2021-2031F

Forecast Period	2027-2031
Market Size (2025)	USD 42.12 Billion
CAGR (2026-2031)	6.99%
Fastest Growing Segment	Equipment
Largest Market	North America
Market Size (2031)	USD 63.18 Billion

Market Overview

The Global Laboratory Supplies Market will grow from USD 42.12 Billion in 2025 to USD 63.18 Billion by 2031 at a 6.99% CAGR. Laboratory supplies encompass the diverse range of consumables, reagents, and instrumentation required for scientific research, clinical diagnostics, and industrial quality testing. The expansion of this market is primarily driven by intensified research and development expenditures within the pharmaceutical and biotechnology sectors, necessitating a continuous supply of high-grade experimental materials. Furthermore, the rising prevalence of chronic diseases has increased the volume of diagnostic testing, while stringent regulatory standards regarding product safety compel industries to maintain rigorous analysis protocols. According to the European Chemical Industry Council, in 2024, Research & Innovation spending in the EU27 chemical industry amounted to €10.4 billion, underscoring the substantial capital investment that sustains demand for these essential resources.

However, the market encounters a significant impediment regarding the high acquisition and maintenance costs associated with advanced analytical equipment. This financial burden can severely strain the operational budgets of smaller research institutions and academic facilities, limiting their ability to procure necessary technologies. Additionally, supply chain volatilities often exacerbate these cost pressures by causing delays and fluctuating prices for critical consumables. Such economic constraints may hinder the adoption of premium laboratory solutions and slow the overall rate of market expansion.

Key Market Drivers

Escalating research and development investments within the pharmaceutical and biotechnology sectors serve as the primary catalyst for the Global Laboratory Supplies Market. As companies race to develop novel therapeutics, particularly in oncology and immunology, the consumption of high-grade reagents, chromatography columns, and plastic consumables has intensified. According to Johnson & Johnson, April 2025, in the '2024 Investor Fact Sheet', the company allocated $17.2 billion toward research and development investment, exemplifying the massive capital fueling this demand. This corporate expenditure directly translates into sustained revenue growth for major equipment providers who must supply the necessary infrastructure for drug discovery. For instance, according to Investing.com, October 2025, in the 'Thermo Fisher Scientific beats Q3 expectations as revenue rises 5%' article, Thermo Fisher Scientific reported that its quarterly revenue grew to $11.12 billion, driven largely by robust operational performance and demand for scientific instruments.

A parallel surge in government funding and grants for life sciences is significantly bolstering market expansion, particularly within academic and non-profit research institutions. Public sector financing is critical for basic science research, which relies heavily on a steady stream of general laboratory supplies and advanced instrumentation to function. According to Congress.gov, December 2025, in the 'National Institutes of Health (NIH) Funding: FY1996-FY2026 Request' report, the NIH received a total program funding level of $46.995 billion for fiscal year 2025. This substantial allocation enables universities and federal laboratories to modernize their infrastructure and procure essential consumables, thereby stabilizing the supply chain demand against the volatility of private sector cycles and ensuring continuous market growth across the diagnostic and biomedical fields.

Download Free Sample Report

Key Market Challenges

The high acquisition and maintenance costs associated with advanced analytical equipment impose a severe constraint on the expansion of the global laboratory supplies market. Sophisticated instrumentation, such as mass spectrometers and automated sequencing platforms, commands prohibitive initial capital investments that are often beyond the reach of smaller research institutions, independent diagnostic labs, and academic centers. This financial barrier limits the total addressable market, as these budget-constrained entities are forced to delay procurement or extend the lifecycle of obsolete machinery rather than upgrading to modern, more efficient technologies. Consequently, the rate of equipment adoption slows, directly reducing the subsequent demand for compatible consumables and reagents which form a significant portion of recurring market revenue.

Furthermore, supply chain volatilities exacerbate these economic challenges by introducing unpredictable fluctuations in the pricing of critical components, further straining operational budgets. When a disproportionate amount of funding is allocated to securing and maintaining hardware, less capital remains for the expansion of experimental capacities. According to the European Federation of Pharmaceutical Industries and Associations, in 2024, the research-based pharmaceutical industry invested an estimated €55 billion in R&D in Europe. While this significant expenditure highlights the sector's scale, it also underscores the immense financial threshold required to sustain operations, effectively concentrating market activity among well-funded giants while creating a challenging environment for smaller players to compete and grow.

Key Market Trends

The implementation of Green Lab Certification programs and sustainable packaging is fundamentally reshaping procurement strategies as institutions strive to decarbonize their supply chains. Laboratories are increasingly prioritizing suppliers that offer verified low-carbon consumables and circular economy solutions to mitigate the environmental impact of plastic waste and chemical disposal. This strategic pivot is evidenced by the industry's growing alignment with rigorous environmental standards to meet corporate climate goals. According to My Green Lab, November 2024, in the 'Carbon Impact of Biotech and Pharma Report', 31% of companies with high-quality emissions data have formally set medium-term Scope 1 and 2 targets aligned with the 1.5°C pathway, signaling a massive compliance-driven shift in purchasing behavior toward certified sustainable products.

Simultaneously, the market is witnessing an accelerated shift toward single-use technologies (SUT) in bioprocessing, driven by the need for greater flexibility and reduced cross-contamination risks in drug manufacturing. Unlike traditional stainless-steel systems, SUTs eliminate time-consuming cleaning validations and allow for rapid facility changeovers, which is critical for the production of complex cell and gene therapies. This operational transition is directly reflected in the substantial revenue generated by specialized technology providers. According to Sartorius, February 2025, in the 'Annual Report 2024', the company's Bioprocess Solutions Division, which primarily focuses on single-use solutions for biopharmaceutical manufacturing, generated sales revenue of €2.69 billion, underscoring the sustained industrial reliance on disposable processing infrastructure.

Segmental Insights

The Equipment segment currently stands as the fastest growing category in the Global Laboratory Supplies Market. This accelerated expansion is primarily driven by the surging demand for automated instrumentation that enhances operational efficiency and accuracy in research workflows. Laboratories are increasingly investing in modern machinery to manage rising testing volumes while significantly reducing manual errors. Furthermore, stringent compliance mandates from regulatory bodies, such as the U.S. Food and Drug Administration, require the adoption of upgraded systems to ensure data integrity. These factors collectively fuel the robust demand for laboratory equipment worldwide.

Regional Insights

North America maintains a leading position in the global laboratory supplies market due to extensive investments in pharmaceutical and biotechnology research. The region hosts a dense concentration of life science companies and academic institutions that generate consistent demand for equipment and consumables. Additionally, stringent regulatory frameworks established by agencies like the U.S. Food and Drug Administration (FDA) mandate rigorous testing protocols, thereby driving the consumption of compliant laboratory products. Sustained financial support from entities such as the National Institutes of Health (NIH) further reinforces the stability of the regional market.

Recent Developments

• In November 2024, Avantor announced the opening of its new flagship Bridgewater Innovation Center in New Jersey, doubling its previous laboratory and pilot plant capacity to support the life sciences industry. The 60,000-square-foot facility was purpose-designed to foster collaborative work, housing spaces for upstream and downstream process development as well as dedicated viral vector laboratories. This expansion aimed to help biopharmaceutical companies accelerate the development of vital therapies, including monoclonal antibodies and cell and gene therapies. The center featured an expanded pilot plant to support scale-up simulations, allowing for rapid customization across the bioprocessing workflow and enhancing the company's ability to solve complex scientific challenges.
• In June 2024, Thermo Fisher Scientific unveiled the Stellar mass spectrometer, a new solution combining fast throughput and high sensitivity to advance translational omics research. The system was designed to bridge the gap between basic science discoveries and clinical applications by streamlining the verification of proteins and metabolites. The President of Chromatography and Mass Spectrometry at Thermo Fisher Scientific highlighted that the instrument achieved significantly higher quantitative sensitivity compared to traditional technologies. This launch aimed to accelerate precision medicine by enabling researchers to analyze a broader range of compounds more efficiently, supporting the conversion of scientific findings into improved human health outcomes.
• In April 2024, Agilent Technologies announced the launch of the Advanced Dilution System (ADS 2), a new automation workflow solution designed to enhance efficiency within analytical laboratories. This intelligent autodilutor was engineered to integrate seamlessly with the company's autosamplers and spectroscopy instruments, offering a fully integrated automated solution. The Vice President and General Manager of Agilent's Atomic Spectroscopy Division noted that the system addressed the growing need for productivity without compromising quality, particularly in food, environmental, and pharmaceutical testing. The technology utilized unique flow paths to optimize analysis speed for both diluted and undiluted samples, thereby lowering the cost of ownership for laboratories.
• In April 2024, Waters Corporation introduced the Alliance iS Bio High Performance Liquid Chromatography (HPLC) System, specifically engineered to address the operational challenges faced by biopharmaceutical quality control laboratories. The system combined advanced bio-separation technology with built-in instrument intelligence to reduce common human errors and boost operational efficiency. According to the Vice President of QA/QC at Waters Corporation, the platform was developed in collaboration with customers to meet evolving compliance requirements and shorten product release timelines. Features such as bio-inert surface technology were included to minimize unwanted analyte interactions, thereby increasing resolution and sensitivity for metal-sensitive analytes in critical quality control environments.

Key Market Players

• Agilent Technologies, Inc.
• Bio-Rad Laboratories, Inc.
• Bruker Corporation
• Danaher Corporation
• FUJIFILM Holdings Corporation
• PerkinElmer Inc.
• Sartorius AG
• Shimadzu Corporation
• Thermo Fisher Scientific Inc.
• Waters Corporation

By Product	By Region
Equipment Disposables	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Laboratory Supplies Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Laboratory Supplies Market, By Product:

• Equipment
• Disposables

• Laboratory Supplies Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE